Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$46.8 - $68.92 $4.83 Million - $7.11 Million
-103,229 Closed
0 $0
Q4 2020

Jan 19, 2021

SELL
$47.96 - $67.64 $1.26 Million - $1.78 Million
-26,319 Reduced 20.32%
103,229 $6.3 Million
Q3 2020

Nov 16, 2020

SELL
$45.41 - $57.07 $3.46 Million - $4.35 Million
-76,261 Reduced 37.05%
129,548 $6.06 Million
Q2 2020

Jul 17, 2020

BUY
$42.56 - $54.98 $7.84 Million - $10.1 Million
184,265 Added 855.3%
205,809 $10.4 Million
Q1 2020

Apr 16, 2020

SELL
$32.37 - $59.36 $1.87 Million - $3.43 Million
-57,731 Reduced 72.82%
21,544 $961,000
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $1.14 Million - $1.78 Million
35,481 Added 81.02%
79,275 $3.81 Million
Q3 2019

Nov 14, 2019

SELL
$33.82 - $48.17 $3.27 Million - $4.66 Million
-96,794 Reduced 68.85%
43,794 $1.48 Million
Q2 2019

Aug 14, 2019

SELL
$35.42 - $45.0 $8.13 Million - $10.3 Million
-229,595 Reduced 62.02%
140,588 $6.33 Million
Q1 2019

May 07, 2019

BUY
$28.09 - $39.49 $5.37 Million - $7.54 Million
191,004 Added 106.6%
370,183 $13.9 Million
Q4 2018

Jan 25, 2019

SELL
$29.83 - $46.51 $9.69 Million - $15.1 Million
-324,838 Reduced 64.45%
179,179 $6.15 Million
Q3 2018

Oct 30, 2018

BUY
$33.9 - $47.77 $15.2 Million - $21.4 Million
447,735 Added 795.52%
504,017 $23.7 Million
Q2 2018

Aug 03, 2018

SELL
$25.7 - $47.88 $15 Million - $28 Million
-583,999 Reduced 91.21%
56,282 $1.9 Million
Q1 2018

Apr 30, 2018

BUY
$17.46 - $32.59 $9.34 Million - $17.4 Million
535,076 Added 508.6%
640,281 $17.3 Million
Q4 2017

Jan 18, 2018

SELL
$15.14 - $20.89 $2.15 Million - $2.97 Million
-142,044 Reduced 57.45%
105,205 $1.76 Million
Q3 2017

Oct 31, 2017

BUY
$16.81 - $21.61 $4.16 Million - $5.34 Million
247,249
247,249 $4.95 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.36B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.